Switzerland Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Switzerland Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: Governments will increasingly impose price controls on pharmaceuticals as drugmakers have generally charged what the market will bear in both developed and emerging markets. While high prices have previously been accepted by patients and national health services, with the advent of health economics, and increasing budget deficits, there will be more caps on medicine expenditure, especially on essential drugs. Aiming to contain costs and improve drug affordability and access, the Swiss government and the pharmaceutical industry struck a short-term deal in April 2013. This was scheduled to come into force on June 1 2013, and run to the … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103226. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/switzerland-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions